BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hosokawa T, Kurosaki M, Tsuchiya K, Matsuda S, Muraoka M, Suzuki Y, Tamaki N, Yasui Y, Nakata T, Nishimura T, Suzuki S, Ueda K, Nakanishi H, Itakura J, Takahashi Y, Izumi N. Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy. World J Gastroenterol 2013; 19(2): 249-257 [PMID: 23345948 DOI: 10.3748/wjg.v19.i2.249]
URL: https://www.wjgnet.com/1948-5182/full/v19/i2/249.htm
Number Citing Articles
1
Guanghua Liu, Fang Xia, Guoping Fan, Juming Yu, Lei Bao, Caiyuan Zhang, Runmin Chi, Tingting Zhang, Lijun Wang, Feng Shen, Dengbin Wang. Type 2 diabetes mellitus worsens the prognosis of intermediate-stage hepatocellular carcinoma after transarterial chemoembolizationDiabetes Research and Clinical Practice 2020; 169: 108375 doi: 10.1016/j.diabres.2020.108375
2
Thanida Tangjarusritaratorn, Watip Tangjittipokin, Tada Kunavisarut. Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without MetforminDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 1563 doi: 10.2147/DMSO.S295753
3
Charupong Saengboonmee, Wunchana Seubwai, Chawalit Pairojkul, Sopit Wongkham. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activationScientific Reports 2016; 6(1) doi: 10.1038/srep18995
4
Wei-Ru Cho, Chih-Chi Wang, Meng-Yun Tsai, Chen-Kai Chou, Yueh-Wei Liu, Yi-Ju Wu, Ming-Tsung Lin, Kuang-Den Chen, Ching-Hui Chuang, Pao-Yuan Huang, Tsung-Hui Hu, Ming-Chao Tsai, Ming-Lung Yu. Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patientsPLOS ONE 2021; 16(3): e0247231 doi: 10.1371/journal.pone.0247231
5
Lung‐Yi Mak, Rex Wan‐Hin Hui, Chi‐Ho Lee, XianHua Mao, Ka‐Shing Cheung, Danny Ka‐Ho Wong, David Tak‐Wai Lui, James Fung, Man‐Fung Yuen, Wai‐Kay Seto. Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetesHepatology 2023; 77(2): 606 doi: 10.1002/hep.32716
6
Nalinie Joharatnam‐Hogan, Pinkie Chambers, Ketan Dhatariya, Ruth Board. A guideline for the outpatient management of glycaemic control in people with cancerDiabetic Medicine 2022; 39(1) doi: 10.1111/dme.14636
7
Tae Young Ryu, Jiyoung Park, Philipp E. Scherer. Hyperglycemia as a Risk Factor for Cancer ProgressionDiabetes & Metabolism Journal 2014; 38(5): 330 doi: 10.4093/dmj.2014.38.5.330
8
Teresa M. Salgado, Rotana M. Radwan, Erin Hickey Zacholski, Emily Mackler, Tonya M. Buffington, Kerri T. Musselman, William J. Irvin, Jennifer M. Perkins, Trang N. Le, Dave L. Dixon, Karen B. Farris, Vanessa B. Sheppard, Resa M. Jones. Oncologists’ responsibility, comfort, and knowledge managing hyperglycemia in patients with cancer undergoing chemotherapy: a cross sectional studySupportive Care in Cancer 2023; 31(8) doi: 10.1007/s00520-023-07927-9
9
Hayato Baba, Makoto Kurano, Takeshi Nishida, Hideki Hatta, Ryoji Hokao, Koichi Tsuneyama. Facilitatory effect of insulin treatment on hepatocellular carcinoma development in diabetesBMC Research Notes 2017; 10(1) doi: 10.1186/s13104-017-2783-6
10
Marin E. Healy, Sujoy Lahiri, Stefan R. Hargett, Jenny D.Y. Chow, Frances L. Byrne, David S. Breen, Brandon M. Kenwood, Evan P. Taddeo, Carolin Lackner, Stephen H. Caldwell, Kyle L. Hoehn. Dietary sugar intake increases liver tumor incidence in female miceScientific Reports 2016; 6(1) doi: 10.1038/srep22292
11
Xian-Fu Sun, Ying-Bo Shao, Ming-Ge Liu, Qi Chen, Zhao-Jun Liu, Bin Xu, Su-Xia Luo, Hui Liu. High-concentration glucose enhances invasion in invasive ductal breast carcinoma by promoting Glut1/MMP2/MMP9 axis expressionOncology Letters 2017; 13(5): 2989 doi: 10.3892/ol.2017.5843
12
Juan Laguna, Marta Alegret, Núria Roglans. Simple Sugar Intake and Hepatocellular Carcinoma: Epidemiological and Mechanistic InsightNutrients 2014; 6(12): 5933 doi: 10.3390/nu6125933
13
R. Barua, A.J. Templeton, B. Seruga, A. Ocana, E. Amir, J.-L. Ethier. Hyperglycaemia and Survival in Solid Tumours: A Systematic Review and Meta-analysisClinical Oncology 2018; 30(4): 215 doi: 10.1016/j.clon.2018.01.003
14
Hande Topel, Ezgi Bağırsakçı, Yeliz Yılmaz, Ayşim Güneş, Gülsün Bağcı, Dehan Çömez, Erkan Kahraman, Peyda Korhan, Neşe Atabey. High glucose induced c-Met activation promotes aggressive phenotype and regulates expression of glucose metabolism genes in HCC cellsScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89765-5
15
Yongxia Qiao, Xiao Zhang, Yue Zhang, Yulan Wang, Yanfeng Xu, Xiangfan Liu, Fenyong Sun, Jiayi Wang. High Glucose Stimulates Tumorigenesis in Hepatocellular Carcinoma Cells Through AGER-Dependent O-GlcNAcylation of c-JunDiabetes 2016; 65(3): 619 doi: 10.2337/db15-1057
16
Su Youn Nam, Jihyeon Jeong, Won Kee Lee, Seong Woo Jeon. Sex-specific effect of body mass index and fasting glucose on gastric cancer risk and all causes mortality; a cohort study of 5.17 millionInternational Journal of Obesity 2022; 46(9): 1644 doi: 10.1038/s41366-022-01161-9
17
Katarina Popovic, Brigita Smolović, Milica Martinović, Ljiljana Vučković. The Relationship between Diabetes Mellitus and Pancreatic Cancer—Diabetes Mellitus as a Red Flag for Pancreatic CancerCancer Epidemiology, Biomarkers & Prevention 2023; 32(3): 298 doi: 10.1158/1055-9965.EPI-22-0951
18
M Zhou, M T S Mok, H Sun, A W Chan, Y Huang, A S L Cheng, G Xu. The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP–PKA–EGFR–STAT3 axisOncogene 2017; 36(29): 4135 doi: 10.1038/onc.2017.38
19
Mathias Jachs, Hans L. Tillmann. It's not all about the virus—On the importance of modifiable lifestyle factors in the development of hepatocellular carcinoma in chronic hepatitis BHepatology 2023; 77(2): 352 doi: 10.1002/hep.32798
20
Yujian Zheng, Qing Cai, Lishan Peng, Shibo Sun, Shaoping Wang, Jie Zhou. Related Factors of Hepatocellular Carcinoma Recurrence Associated With Hyperglycemia After Liver TransplantationTransplantation Proceedings 2021; 53(1): 177 doi: 10.1016/j.transproceed.2020.10.027
21
Chin-Wen Kuo, Hsiang-Ling Wu, Chun-Cheng Li, Juan P. Cata, Hsin-Yi Liu, Ming-Chih Hou, Yih-Giun Cherng, Ying-Hsuan Tai. Long-Term Survival Impact of High-Grade Complications after Liver Resection for Hepatocellular Carcinoma: A Retrospective Single-Centre Cohort StudyMedicina 2022; 58(4): 534 doi: 10.3390/medicina58040534
22
Chihiro Dohi, Kazuhiro Nouso, Koji Miyahara, Yuki Morimoto, Nozomu Wada, Hideaki Kinugasa, Yasuto Takeuchi, Kenji Kuwaki, Hideki Onishi, Fusao Ikeda, Shinichiro Nakamura, Hidenori Shiraha, Akinobu Takaki, Hiroyuki Okada. Potential of alpha‐fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinomaHepatology Research 2016; 46(9): 916 doi: 10.1111/hepr.12636
23
Claudio Fiorillo, Giuseppe Quero, Vito Laterza, Pietro Mascagni, Fabio Longo, Roberta Menghi, Francesco Razionale, Fausto Rosa, Teresa Mezza, Ivo Boskoski, Andrea Giaccari, Sergio Alfieri. Postoperative hyperglycemia affects survival after gastrectomy for cancer: A single-center analysis using propensity score matchingSurgery 2020; 167(5): 815 doi: 10.1016/j.surg.2019.11.006
24
Kazuto Tajiri, Hayato Baba, Kengo Kawai, Masami Minemura, Satoshi Yasumura, Terumi Takahara, Toshiro Sugiyama. Neutrophil‐to‐lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infectionJournal of Gastroenterology and Hepatology 2016; 31(7): 1291 doi: 10.1111/jgh.13287
25
Victor M. Lu, Anshit Goyal, Lachlin S. Vaughan, Kerrie L. McDonald. The impact of hyperglycemia on survival in glioblastoma: A systematic review and meta-analysisClinical Neurology and Neurosurgery 2018; 170: 165 doi: 10.1016/j.clineuro.2018.05.020
26
Suangson Supabphol, Wunchana Seubwai, Sopit Wongkham, Charupong Saengboonmee. High glucose: an emerging association between diabetes mellitus and cancer progressionJournal of Molecular Medicine 2021; 99(9): 1175 doi: 10.1007/s00109-021-02096-w
27
Bhrigu Kumar Das, S.M. Choukimath, Pramod C. Gadad. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieuLife Sciences 2019; 230: 10 doi: 10.1016/j.lfs.2019.05.046
28
Marutpong Detarya, Salak Thaenkaew, Wunchana Seubwai, Somsiri Indramanee, Chatchai Phoomak, Charupong Saengboonmee, Sopit Wongkham, Chaisiri Wongkham. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinomaLife Sciences 2021; 271: 119114 doi: 10.1016/j.lfs.2021.119114
29
Toshiya Atsumi. Diabetes and risk of cancerDiabetology International 2015; 6(3): 190 doi: 10.1007/s13340-015-0227-x
30
Surbhi Chouhan, Snahlata Singh, Dipti Athavale, Pranay Ramteke, Vimal Pandey, Jomon Joseph, Rajashekar Mohan, Praveen Kumar Shetty, Manoj Kumar Bhat. Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4Scientific Reports 2016; 6(1) doi: 10.1038/srep27558
31
S. Uslu, N. Alaca, K. D. Kilic, A. Uysal, H. Kurtel. The effects of aerobic exercise frequencies on liver fibrosis, α-fetoprotein and cytokeratin 19 in experimental type 2 diabetes-induced rats: an immunohistochemistry studyBiotechnic & Histochemistry 2018; 93(8): 615 doi: 10.1080/10520295.2018.1517898
32
Jeong-Ju Yoo, Eun Ju Cho, Kyungdo Han, Soo Seong Heo, Bo-Yeon Kim, Dong Wook Shin, Su Jong Yu. Glucose Variability and Risk of Hepatocellular Carcinoma in Patients with Diabetes: A Nationwide Population-Based StudyCancer Epidemiology, Biomarkers & Prevention 2021; 30(5): 974 doi: 10.1158/1055-9965.EPI-20-1654
33
Daryl Ramai, Waqqas Tai, Michelle Rivera, Antonio Facciorusso, Nicola Tartaglia, Mario Pacilli, Antonio Ambrosi, Christian Cotsoglou, Rodolfo Sacco. Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular CarcinomaBiomedicines 2021; 9(2): 184 doi: 10.3390/biomedicines9020184
34
Charupong Saengboonmee, Chatchai Phoomak, Suangson Supabphol, Kyle R. Covington, Oliver Hampton, Chaisiri Wongkham, Richard A. Gibbs, Kazuo Umezawa, Wunchana Seubwai, Marie-Claude Gingras, Sopit Wongkham. NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cellsLife Sciences 2020; 262: 118548 doi: 10.1016/j.lfs.2020.118548
35
G. Ariaans, S. de Jong, J.A. Gietema, J.D. Lefrandt, E.G.E. de Vries, M. Jalving. Cancer-drug induced insulin resistance: Innocent bystander or unusual suspectCancer Treatment Reviews 2015; 41(4): 376 doi: 10.1016/j.ctrv.2015.02.007
36
Úna C. McMenamin, Stephen McCain, Andrew T. Kunzmann. Do smoking and alcohol behaviours influence GI cancer survival?Best Practice & Research Clinical Gastroenterology 2017; 31(5): 569 doi: 10.1016/j.bpg.2017.09.015
37
Baoqing Zhao, Mengxi Li, Yanting Su, Shigang Shan, Wenbin Qian, Dan Zhu, Xiufen Liu, Zhenwang Zhang. Role of transcription factor FOXM1 in diabetes and its complications (Review)International Journal of Molecular Medicine 2023; 52(5) doi: 10.3892/ijmm.2023.5304